Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma

Eli Lilly and Company · 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
solid tumor, non-small cell lung cancer recurrent, hepatocellular carcinoma recurrent, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 813547
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.